Oncolytic vaccinia virus induces a novel phenotype of CD8<sup>+</sup> effector T cells characterized by high ICOS expression.

Oncolytic vaccinia virus induces a novel phenotype of CD8⁺ effector T cells characterized by high ICOS expression.

Yamashita, Midori; Tasaki, Mamoru; Murakami, Ryuji; Arai, Yukinori; Nakamura, Takafumi; Nakao, Shinsuke.

Afiliação

Yamashita M; Drug Discovery Research, Astellas Pharma, Inc., 21, Miyukigaoka, Tsukuba 305-8585, Japan.
Tasaki M; Drug Discovery Research, Astellas Pharma, Inc., 21, Miyukigaoka, Tsukuba 305-8585, Japan.
Murakami R; Drug Discovery Research, Astellas Pharma, Inc., 21, Miyukigaoka, Tsukuba 305-8585, Japan.
Arai Y; Drug Discovery Research, Astellas Pharma, Inc., 21, Miyukigaoka, Tsukuba 305-8585, Japan.
Nakamura T; Department of Biomedical Science, Graduate School of Medical Sciences, Tottori University, 86 Nishi-cho, Yonago 683-8503, Japan.
Nakao S; Drug Discovery Research, Astellas Pharma, Inc., 21, Miyukigaoka, Tsukuba 305-8585, Japan.

Mol Ther Oncolytics ; 20: 422-432, 2021 Mar 26.

Article em En | MEDLINE | ID: mdl-33665362